Whole-Body (18) FDG-PET in an Arthritis Paraneoplastic Syndrome Revealed an Underlying Hematological Neoplasm.
作者信息
Cammilleri Serge, Guzian Marie Caroline, Mattei Jean-Pierre, Mundler Olivier, Guis Sandrine
机构信息
Service de Médecine Nucléaire, AP-HM, Faculté de Médecine de Marseille, Hôpital La Timone, Aix-Marseille University, 27 Boulevard Jean Moulin, 13005 Marseille, France.
出版信息
Case Rep Med. 2013;2013:594704. doi: 10.1155/2013/594704. Epub 2013 Jun 2.
Abstract
We showed the first image of (18)FDG-PET, which leads to a diagnosis of lymphoma in an atypical polyarthritis. About 4% of patients with lymphoma or leukemia suffered from rheumatologic paraneoplastic symptoms like arthralgia and about 10% of the patients with rheumatologic or neurologic clinical symptoms develop a solid cancer or hematological neoplasm. (18)FDG-PET is an interesting exam to identify an underlying malignancy when a paraneoplastic syndrome is suspected; it can detect the primitive lesion and/or the metastasis lesions. The use of the (18)FDG-PET can help to detect earlier hematological neoplasm in cases of paraneoplastic syndrome without a determined cause and to treat more rapidly and specifically the patient.
摘要
相似文献
1
Whole-Body (18) FDG-PET in an Arthritis Paraneoplastic Syndrome Revealed an Underlying Hematological Neoplasm.
Case Rep Med. 2013;2013:594704. doi: 10.1155/2013/594704. Epub 2013 Jun 2.
2
Whole-Body F-FDG PET and F-FDG PET/CT in Patients with Suspected Paraneoplastic Syndrome: A Systematic Review and Meta-Analysis of Diagnostic Accuracy.
J Nucl Med. 2017 Jul;58(7):1031-1036. doi: 10.2967/jnumed.116.183905. Epub 2016 Dec 15.
3
F-Fluorodeoxyglucose positron-emission tomography for the investigation of malignancy in patients with suspected paraneoplastic neurologic syndromes and negative or indeterminate conventional imaging: a retrospective analysis of the Ontario PET Access Program, with systematic review and meta-analysis.
Curr Oncol. 2019 Aug;26(4):e458-e465. doi: 10.3747/co.26.4583. Epub 2019 Aug 1.
4
[Bone and calcium metabolism associated with malignancy. Paraneoplastic rheumatologic musculoskeletal manifestations.].
Clin Calcium. 2018;28(11):1479-1484.
5
FDG-PET improves tumour detection in patients with paraneoplastic neurological syndromes.
Brain. 2004 Oct;127(Pt 10):2331-8. doi: 10.1093/brain/awh247. Epub 2004 Sep 10.
6
[Paraneoplastic rheumatologic syndromes in the elderly].
Wiad Lek. 2019;72(9 cz 1):1646-1654.
7
Role of FDG-PET in the clinical management of paraneoplastic neurological syndrome: detection of the underlying malignancy and the brain PET-MRI correlates.
Mol Imaging Biol. 2008 May-Jun;10(3):131-7. doi: 10.1007/s11307-008-0134-7. Epub 2008 Feb 23.
8
Utility of 18F-FDG-PET/CT in patients suspected of paraneoplastic neurological syndrome: importance of risk classification.
Clin Transl Oncol. 2017 Jan;19(1):111-118. doi: 10.1007/s12094-016-1511-3. Epub 2016 May 2.
9
F-fluorodeoxyglucose positron emission tomography/ computed tomography in the diagnosis of suspected paraneoplastic syndromes: A retrospective analysis.
World J Nucl Med. 2020 Jan 17;19(2):124-130. doi: 10.4103/wjnm.WJNM_48_19. eCollection 2020 Apr-Jun.
10
Migratory polyarthritis as a paraneoplastic syndrome in a patient with diffuse large B cell lymphoma: a case report.
J Med Case Rep. 2018 Jun 26;12(1):189. doi: 10.1186/s13256-018-1700-5.
引用本文的文献
1
Circulating microparticles bearing Fibrin associated with whole-body 18FDG-PET: diagnostic tools to detect paraneoplastic polymyalgia rheumatica.
Rheumatol Int. 2016 Aug;36(8):1099-103. doi: 10.1007/s00296-016-3510-7. Epub 2016 Jun 20.
2
Migrating Polyarthritis as a Feature of Occult Malignancy: 2 Case Reports and a Review of the Literature.
Case Rep Oncol Med. 2015;2015:934039. doi: 10.1155/2015/934039. Epub 2015 Oct 19.
3
Positron emission tomography findings in a patient with multiple myeloma of polymyalgia rheumatica-like symptoms caused by paraneoplastic syndrome.
BMJ Case Rep. 2014 Apr 9;2014:bcr2013203326. doi: 10.1136/bcr-2013-203326.
本文引用的文献
1
Utility of F-18 FDG PET/CT in screening for paraneoplastic neurological syndromes.
Clin Nucl Med. 2012 Jan;37(1):39-43. doi: 10.1097/RLU.0b013e3182393390.
2
Paraneoplastic rheumatic syndromes: report of eight cases and review of literature.
Rheumatol Int. 2012 Jun;32(6):1485-9. doi: 10.1007/s00296-011-2252-9. Epub 2011 Nov 17.
3
PET imaging in a longitudinal non-Hodgkin's lymphoma study: association with tumor volume.
Acta Radiol. 2011 Nov 1;52(9):995-1002. doi: 10.1258/ar.2011.110099. Epub 2011 Sep 23.
4
Predictive value of initial 18F-FLT uptake in patients with aggressive non-Hodgkin lymphoma receiving R-CHOP treatment.
J Nucl Med. 2011 May;52(5):690-6. doi: 10.2967/jnumed.110.084566. Epub 2011 Apr 15.
5
The role of routine imaging procedures in the detection of relapse of patients with Hodgkin lymphoma and aggressive non-Hodgkin lymphoma.
Ann Hematol. 2011 Feb;90(2):165-71. doi: 10.1007/s00277-010-1044-8. Epub 2010 Aug 13.
6
Incidental detection of acute lymphoblastic leukemia on [18F]fluorodeoxyglucose positron emission tomography.
J Clin Oncol. 2009 Dec 20;27(36):e269-70. doi: 10.1200/JCO.2009.22.7769. Epub 2009 Oct 13.
7
Role of chemotherapy in Hodgkin's lymphoma.
Cancer J. 2009 Mar-Apr;15(2):150-4. doi: 10.1097/PPO.0b013e3181a27018.
8
Characteristics and survival of 26 patients with paraneoplastic arthritis.
Ann Rheum Dis. 2008 Feb;67(2):244-7. doi: 10.1136/ard.2007.070086. Epub 2007 Jun 29.
9
18F-FDG PET for evaluation of bone marrow infiltration in staging of lymphoma: a meta-analysis.
J Nucl Med. 2005 Jun;46(6):958-63.
10
Paraneoplastic rheumatic syndromes.
Baillieres Best Pract Res Clin Rheumatol. 2000 Sep;14(3):515-33. doi: 10.1053/berh.2000.0091.
Zotero 插件